pills

Healthcare DECODED

Previous edition: 20 May 2024
Share article

Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now

HCG to open two cancer care centres in Bengaluru, India next year

The facilities, planned to be located in Whitefield and North Bengaluru areas, will have a combined capacity of 125 beds.

India based cancer care provider Healthcare Global Enterprises (HCG) has confirmed its plans to open two new comprehensive cancer care centres in Bengaluru, Karnataka, India.  

These two facilities, which are planned to be located in the Whitefield and North Bengaluru areas, are expected to begin operations from early 2025.  

HCG said that the new centres are being opened as part of its strategic expansion plan to provide advanced and specialised cancer treatments to the densely populated areas of the city, adding to its existing Bengaluru hospital network. 

These two centres will be HCG’s third and fourth hospitals in Bengaluru.  

The strategically located centres will offer a wide range of cancer care services, from precise diagnostics to tailored treatment plans, all at one location.  

Each facility will contribute to the network's capacity with a combined total of 125 beds.  

These additions will complement HCG's flagship Centre of Excellence at KR Road and Double Road, Bengaluru, which together house 300 beds. 

HCG's expansion in Bengaluru also includes plans for two new day care centres, aimed at reducing travel times and improving accessibility for patients requiring frequent treatments such as chemotherapy.  

These will add to the existing three daycare centres in the residential areas of Banashankari, Kalyan Nagar, and Malleshwaram. 

The North Bengaluru centre will be equipped with the MR LINAC radiation system, a technology that combines magnetic resonance imaging (MRI) with a linear accelerator (LINAC).  

According to the company, the use of this system is expected to enhance radiation therapy in the state by enhancing clinical outcomes, minimising side effects, and shortening treatment durations. 

HCG currently includes 21 comprehensive cancer centres, 24 hospitals across India and Africa, as well as seven daycare centres.  

Healthcare Global Enterprises executive chairman Dr B S Ajaikumar said: “Our new advanced centres at Whitefield and North Bengaluru are pivotal to our aim of extending our network to the local community sustainably, ensuring high-quality cancer care is accessible to all.  

“With Bengaluru being HCG's home ground, this expansion not only reflects our deep-rooted connection to the city but also our commitment to enhancing the healthcare landscape for the benefit of the local community."  

Latest news

Fracture Liaison Service launches in Mid and South Essex

The service aims to strengthen the bones of individuals over 50, reduce fracture risks, and alleviate hospital bed occupancy.

Burjeel opens new Day Surgery Center in Al Ain, Abu Dhabi

The centre will reduce long hospital stays by offering advanced surgical interventions to treat several medical conditions.

PureHealth launches platform for mental health

Sakina introduces services such as neurodiversity centres, inpatient institutes, satellite clinics, and mental health hubs.

Maine Medical Center's new Malone Family Tower to open next month

The tower will add 96 private patient rooms, nine procedure rooms, ten operating rooms, and 40 pre- and post-procedure beds.

L&T to build new medical campus for Institute of Neurosciences Kolkata, India

The company has categorised the new order as “significant”, which is valued in the range of $119.9m to $299.7m.

athenahealth introduces new specialty care offerings

The two new offerings incorporate the comprehensive features of athenahealth's EHR and practice management solutions.

FDA approve Medtronic‘s SCS device, Inceptiv

Medtronic plc, a global leader in healthcare technology, announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.

Post-Operative Pain Drugs Assessment

Understand the trends shaping and driving the Post-Operative Pain (POP) market and develop your strategies accordingly.

See a Sample

Newsletters in other sectors

Travel and Tourism

Las Vegas landmark the Mirage to close doors
20 May 2024

Explore our market-leading Intelligence Centers

Still looking?

Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries

Explorer

Access more premium companies when you subscribe to Explorer